46 related articles for article (PubMed ID: 35064453)
1. Results from the UNITED study: a multicenter study validating the prognostic effect of the tumor-stroma ratio in colon cancer.
Polack M; Smit MA; van Pelt GW; Roodvoets AGH; Meershoek-Klein Kranenbarg E; Putter H; Gelderblom H; Crobach ASLP; Terpstra V; Petrushevska G; Gašljević G; Kjær-Frifeldt S; de Cuba EMV; Bulkmans NWJ; Vink GR; Al Dieri R; Tollenaar RAEM; van Krieken JHJM; Mesker WE;
ESMO Open; 2024 Apr; 9(4):102988. PubMed ID: 38613913
[TBL] [Abstract][Full Text] [Related]
2. Tumour deposits are independently associated with recurrence in colon cancer.
Hakki L; Khan A; Do E; Gonen M; Firat C; Vakiani E; Shia J; Widmar M; Wei IH; Smith JJ; Pappou EP; Nash GM; Paty PB; Garcia-Aguilar J; Weiser MR
Colorectal Dis; 2024 Mar; 26(3):459-465. PubMed ID: 38263577
[TBL] [Abstract][Full Text] [Related]
3. Tumour-stroma ratio has poor prognostic value in non-pedunculated T1 colorectal cancer: A multi-centre case-cohort study.
Dang H; van Pelt GW; Haasnoot KJ; Backes Y; Elias SG; Seerden TC; Schwartz MP; Spanier BW; de Vos Tot Nederveen Cappel WH; van Bergeijk JD; Kessels K; Geesing JM; Groen JN; Ter Borg F; Wolfhagen FH; Seldenrijk CA; Raicu MG; Milne AN; van Lent AU; Brosens LA; Offerhaus GJA; Siersema PD; Tollenaar RA; Hardwick JC; Hawinkels LJ; Moons LM; Lacle MM; Mesker WE; Boonstra JJ;
United European Gastroenterol J; 2020 Nov; 9(4):2050640620975324. PubMed ID: 33210982
[TBL] [Abstract][Full Text] [Related]
4. Impact of tumour stroma-immune interactions on survival prognosis and response to neoadjuvant chemotherapy in bladder cancer.
Liu L; Xu L; Wu D; Zhu Y; Li X; Xu C; Chen K; Lin Y; Lao J; Cai P; Li X; Luo Y; Li X; Huang J; Lin T; Zhong W
EBioMedicine; 2024 Jun; 104():105152. PubMed ID: 38728838
[TBL] [Abstract][Full Text] [Related]
5. A computed tomography-based multitask deep learning model for predicting tumour stroma ratio and treatment outcomes in patients with colorectal cancer: a multicentre cohort study.
Cui Y; Zhao K; Meng X; Mao Y; Han C; Shi Z; Yang X; Tong T; Wu L; Liu Z
Int J Surg; 2024 May; 110(5):2845-2854. PubMed ID: 38348900
[TBL] [Abstract][Full Text] [Related]
6. Brief report: Lymph node morphology in stage II colorectal cancer.
Greenwood A; Keating J; Kenwright D; Shekouh A; Dalzell A; Dennett E; Danielson K
PLoS One; 2021; 16(3):e0249197. PubMed ID: 33780511
[TBL] [Abstract][Full Text] [Related]
7. Low Tumor-to-Stroma Ratio Reflects Protective Role of Stroma against Prostate Cancer Progression.
Nastały P; Smentoch J; Popęda M; Martini E; Maiuri P; Żaczek AJ; Sowa M; Matuszewski M; Szade J; Kalinowski L; Niemira M; Brandt B; Eltze E; Semjonow A; Bednarz-Knoll N
J Pers Med; 2021 Oct; 11(11):. PubMed ID: 34834440
[TBL] [Abstract][Full Text] [Related]
8. LGR6 is a prognostic biomarker for less differentiated tumors in lymph nodes of colon cancer patients.
Eltorky H; AbdelMageed M; Ismail H; Zahran F; Guirgis A; Olsson L; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
Front Oncol; 2024; 14():1393075. PubMed ID: 38715790
[TBL] [Abstract][Full Text] [Related]
9. High grade leiomyosarcoma of the transverse colon with positive lymph node metastasis: to treat or not to treat with adjuvant radiation therapy?
Jenkins P; Joiner M; Kumar A; Miller SR
BMJ Case Rep; 2023 Jun; 16(6):. PubMed ID: 37336627
[TBL] [Abstract][Full Text] [Related]
10. Stroma AReactive Invasion Front Areas (SARIFA): a novel histopathologic biomarker in colorectal cancer patients and its association with the luminal tumour proportion.
Reitsam NG; Grosser B; Enke JS; Mueller W; Westwood A; West NP; Quirke P; Märkl B; Grabsch HI
Transl Oncol; 2024 Jun; 44():101913. PubMed ID: 38593584
[TBL] [Abstract][Full Text] [Related]
11. TNM-O: ontology support for staging of malignant tumours.
Boeker M; França F; Bronsert P; Schulz S
J Biomed Semantics; 2016 Nov; 7(1):64. PubMed ID: 27842575
[TBL] [Abstract][Full Text] [Related]
12. Exploring prognostic values of DNA ploidy, stroma-tumor fraction and nucleotyping in stage II colon cancer patients.
Lou Y; Yang L; Xu S; Tan L; Bai Y; Wang L; Sun T; Zhou L; Feng L; Lian S; Wu A; Li Z
Discov Oncol; 2024 Jun; 15(1):227. PubMed ID: 38874696
[TBL] [Abstract][Full Text] [Related]
13. Deep Learning Prediction of Metastasis in Locally Advanced Colon Cancer Using Binary Histologic Tumor Images.
Schiele S; Arndt TT; Martin B; Miller S; Bauer S; Banner BM; Brendel EM; Schenkirsch G; Anthuber M; Huss R; Märkl B; Müller G
Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33922988
[TBL] [Abstract][Full Text] [Related]
14. Cellular and Molecular Mechanisms of the Tumor Stroma in Colorectal Cancer: Insights into Disease Progression and Therapeutic Targets.
Shakhpazyan N; Mikhaleva L; Bedzhanyan A; Gioeva Z; Sadykhov N; Mikhalev A; Atiakshin D; Buchwalow I; Tiemann M; Orekhov A
Biomedicines; 2023 Aug; 11(9):. PubMed ID: 37760801
[TBL] [Abstract][Full Text] [Related]
15. Node-negative colon cancer: histological, molecular, and stromal features predicting disease recurrence.
Strous MTA; van der Linden RLA; Gubbels ALHM; Faes TKE; Bosscha K; Bronkhorst CM; Janssen-Heijnen MLG; de Bruïne AP; Vogelaar FJ
Mol Med; 2023 Jun; 29(1):77. PubMed ID: 37344790
[TBL] [Abstract][Full Text] [Related]
16. Tumour-stroma ratio (TSR) in breast cancer: comparison of scoring core biopsies versus resection specimens.
Karancsi Z; Hagenaars SC; Németh K; Mesker WE; Tőkés AM; Kulka J
Virchows Arch; 2023 May; ():. PubMed ID: 37198327
[TBL] [Abstract][Full Text] [Related]
17. Development of Tier 2 LC-MRM-MS protein quantification methods for liquid biopsies.
Diederiks N; Ravensbergen CJ; Treep M; van Wezel M; Kuruc M; Renee Ruhaak L; Tollenaar RAEM; Cobbaert CM; van der Burgt YEM; Mesker WE
J Mass Spectrom Adv Clin Lab; 2023 Jan; 27():49-55. PubMed ID: 36619217
[TBL] [Abstract][Full Text] [Related]
18. KIT promotes tumor stroma formation and counteracts tumor-suppressive TGFβ signaling in colorectal cancer.
Küçükköse E; Peters NA; Ubink I; van Keulen VAM; Daghighian R; Verheem A; Laoukili J; Kranenburg O
Cell Death Dis; 2022 Jul; 13(7):617. PubMed ID: 35842424
[TBL] [Abstract][Full Text] [Related]
19. A high tumour-stroma ratio (TSR) in colon tumours and its metastatic lymph nodes predicts poor cancer-free survival and chemo resistance.
Strous MTA; Faes TKE; Gubbels ALHM; van der Linden RLA; Mesker WE; Bosscha K; Bronkhorst CM; Janssen-Heijnen MLG; Vogelaar FJ; de Bruïne AP
Clin Transl Oncol; 2022 Jun; 24(6):1047-1058. PubMed ID: 35064453
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
